Ori Cheshnovsky, the scientific advisor for the Dan David Prize, told Retraction Watch that everyone involved “was aware of Dr. Croce’s retractions and the allegations:”

The international ad-hoc committee for Personalized Medicine composed of the most respected, top scientists, recommended to award the Prize to Prof. Carlo Croce in view of his proven singular contributions to Personalized Medicine. The Dan David Prize Board accepted the committee’s recommendation.

The committee that recommended Croce for the Dan David Prize was chaired by one of Croce’s long-time collaborators Peter Vogt, who runs a lab at The Scripps Research Institute in La Jolla, California. (Vogt and Croce were coauthors on a 2017 paper in PNAS). Croce has also co-authored several papers with two other members of the committee—Webster K. Cavenee and Nancy Jenkins.

[Croce] is a pioneer in the unraveling of the molecular basis of a number of lymphoma and leukemia cancers. Mastering both cytogenetics and molecular biology, he identified the role of major oncogenes as drivers of cancer development, progression and resistance to therapy.

RETRACTION
Volume 21, no. 7, p. 2485–2495, 2001, https://doi.org/10.1128/MCB.21.7.2485-2495.2001. The publisher hereby retracts this article. Questions have been raised by concerned readers about the integrity of the data. The American Society for Microbiology has reviewed the figures and confirmed evidence of apparent manipulation and duplication. Since the integrity of the data as presented was compromised, this publication is retracted in its entirety. We apologize to the readers of Molecular and Cellular Biology and regret any inconvenience that this causes. The authors did not agree to this retraction.